Cart (0)
No products in the cart.
Biotics Research – FC-Cidal™
Supplement Facts:
Amount Per Serving:
- Berberine sulfate – 400 mg
- Wormwood (Artemisia absinthium) extract (leaf) – 300 mg
- Thyme (Thymus vulgaris) extract (leaf) – 200 mg
- Sage (Salvia officinalis) extract (leaf) – 150 mg
- Black walnut (Juglans nigra) hull powder – 100 mg
- Bearberry (Arctostaphylos uva-ursi) extract (leaf) – 100 mg
- Garlic (Allium sativum) extract (bulb) – 100 mg
*Daily Value (DV) not established.
Other Ingredients: Capsule shell (gelatin), cellulose, magnesium stearate, silica.
Free Shipping
For all orders over $200
1 & 1 Returns
Cancellation after 1 day
Secure Payment
Guarantee secure payments
Hotline Order:
24/7
+923186763953
Become a Vendor?Register now
Biotics Research – FC-Cidal™ in Pakistan
FC-Cidal™ by Biotics Research is a broad-spectrum herbal supplement formulated to support a healthy gastrointestinal (GI) microbiome. It helps promote balanced intestinal flora, digestive comfort, and overall gut wellness using a combination of potent botanical extracts.
Formulated with potent botanicals traditionally used for gut and immune health, FC-Cidal™ helps support the natural detoxification process, maintain intestinal flora balance, and promote optimal digestive function.
Trusted by healthcare practitioners since 1976, Biotics Research delivers science-based nutrition with uncompromised quality.
Key Benefits:
- Supports a balanced gut microbiome
- Helps manage intestinal microbial overgrowth
- Promotes digestive comfort and health
- Broad-spectrum herbal antimicrobial support
- Trusted by healthcare practitioners
Directions for Use:
Take 2 capsules twice daily with meals, or as directed by your healthcare professional.
Warnings:
- For adult use only
- Consult your physician if pregnant, nursing, or under medical supervision
- Store in a cool, dry place
- Keep out of reach of children
Add your review
Your email address will not be published. Required fields are marked *
Please login to write review!
Looks like there are no reviews yet.
